GREENWICH LIFESCIENC

GLSI
Delayed Quote. Delayed  - 01/19 04:00:00 pm
37.27USD -0.48%

GREENWICH LIFESCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

11/24/2020 | 07:02am

Item 8.01 Other Events.



On November 23, 2020, Greenwich LifeSciences, Inc. (the "Company") announced the
publication of a second abstract at the San Antonio Breast Cancer Symposium
(SABCS), jointly authored by Professor Mothaffar F. Rimawi, the Global Principal
Investigator of the GP2 Phase III clinical trial, and the Executive Medical
Director and Co-Leader of the Breast Cancer Program at the Dan L Duncan
Comprehensive Cancer Center
at Baylor College of Medicine, and Professor C. Kent
Osborne
, Tina and Dudley Sharp Chair in Oncology and the founding Director of
the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. The
abstract will be displayed as the Company's second poster on Wednesday, December
9, 2020
in a virtual format with an introductory audio track. A copy of the
press release is attached hereto as Exhibit 99.1and is incorporated herein by
reference.



Item 9.01 Financial Statements and Exhibits.






(d) Exhibits.




Exhibit No. Description

99.1 Press release dated November 23, 2020




-2-

© Edgar Online, source Glimpses

© Acquiremedia 2021
Copier lien
All news about GREENWICH LIFESCIENCES, INC.
01/08
01/05
12/24
12/22
12/22